Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T17048 | Target Info | |||
Target Name | DNA topoisomerase II alpha (TOP2A) | ||||
Synonyms | DNA topoisomerase II, alpha isozyme; DNA topoisomerase 2alpha; DNA topoisomerase 2-alpha | ||||
Target Type | Clinical trial Target | ||||
Gene Name | TOP2A | ||||
Biochemical Class | Topoisomerase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Carbon-nitrogen hydrolases | [+] 1 Carbon-nitrogen hydrolases | + | |||
Interacting Target Name | Histone deacetylase 1 (HDAC1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | RPD3L1; HD1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [1] | |||
2 | Reconstituted Complex | [2] | |||
Isomerases | [+] 1 Isomerases | + | |||
Interacting Target Name | DNA topoisomerase II beta (TOP2B) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Topo IIbeta; TOP2beta; TOP2B | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-fractionation | [3] | |||
2 | Reconstituted Complex | [4] | |||
Kinases | [+] 1 Kinases | + | |||
Interacting Target Name | Casein kinase II alpha (CSNK2A1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Protein kinase CK2; CK2A1; CK II alpha; CK II; Casein kinase II subunit alpha | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Biochemical Activity | [5] | |||
2 | Co-fractionation | [6] | |||
Peptidases | [+] 1 Peptidases | + | |||
Interacting Target Name | JUN activation domain binding protein (COPS5) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Signalosome subunit 5; SGN5; Jun activation domain-binding protein 1; JAB1; CSN5; COP9 signalosome complex subunit 5 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [7] | |||
2 | Yeast two hybrid | [8] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Target Name | Beta-catenin (CTNNB1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Wnt/beta-catenin signaling pathway; PRO2286; OK/SW-cl.35; CTNNB; Catenin beta-1 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [9] | |||
2 | Affinity Capture-Western | [9] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Histone deacetylase interacts directly with DNA topoisomerase II. Nat Genet. 2000 Nov;26(3):349-53. | ||||
REF 2 | Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis. J Biol Chem. 2001 Feb 16;276(7):4539-42. | ||||
REF 3 | A census of human soluble protein complexes. Cell. 2012 Aug 31;150(5):1068-81. | ||||
REF 4 | Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8288-93. | ||||
REF 5 | A bead-based approach for large-scale identification of in vitro kinase substrates. Proteomics. 2011 Dec;11(24):4632-7. | ||||
REF 6 | Panorama of ancient metazoan macromolecular complexes. Nature. 2015 Sep 17;525(7569):339-44. | ||||
REF 7 | Novel mechanism by which histone deacetylase inhibitors facilitate topoisomerase II degradation in hepatocellular carcinoma cells. Hepatology. 2011 Jan;53(1):148-59. | ||||
REF 8 | Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5. J Biol Chem. 2004 Jul 23;279(30):31296-303. | ||||
REF 9 | Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. Gastroenterology. 2005 Oct;129(4):1225-36. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.